Emergence of a Novel SARS-CoV-2 Variant in Southern California

Nextstrain: real-time tracking of pathogen evolution

Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154

GISAID: Global initiative on sharing all influenza data – from vision to reality

Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.012 · Cited by 1,420

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178

Genetic Variants of SARS-CoV-2—What Do They Mean?

Lauring, A. S., & Hodcroft, E. B. (2021) · JAMA · doi:10.1001/jama.2020.27124 · Cited by 604

Emergence of a new SARS-CoV-2 variant in the UK

Tang, J. W.-T., Tambyah, P. A., & Hui, D. S. C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.024 · Cited by 273

Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic

Zhang, W., Govindavari, J. P., Davis, B. D., Chen, S. S., Kim, J. T., Song, J., Lopategui, J. R., Plummer, J., & Vail, E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.24191 · Cited by 36

S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the USPreprint

Washington, N. L., White, S. J., Barrett, K. M. S., Cirulli, E. T., Bolze, A., & Lu, J. T. (2020) · medRxiv · doi:10.1101/2020.12.24.20248814 · Cited by 35

A k-mer Based Approach for SARS-CoV-2 Variant Identification

Ali, S., Sahoo, B., Ullah, N., Zelikovsky, A., Patterson, M., & Khan, I. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-91415-8_14 · Cited by 44

Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein

Gerdol, M., Dishnica, K., & Giorgetti, A. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198674 · Cited by 47

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice

Rice, A., Verma, M. S., Shin, A., Zakin, L., Sieling, P. A., Tanaka, S., Balint, J. P., Dinkins, K., Adisetiyo, H., Morimoto, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94364-5 · Cited by 43

Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco

Peng, J., Liu, J., Mann, S. A., Mitchell, A. M., Laurie, M. T., Sunshine, S., Pilarowski, G., Ayscue, P., Kistler, A., Vanaerschot, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab283 · Cited by 41

Postvaccination SARS‐CoV‐2 infection among healthcare workers: A systematic review and meta‐analysis

Chandan, S., Khan, S. R., Deliwala, S. S., Mohan, B. P., Ramai, D., Chandan, O. C., & Facciorusso, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27457 · Cited by 40

Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada

Matic, N., Lowe, C. F., Ritchie, G., Stefanovic, A., Lawson, T., Jang, W., Young, M., Dong, W. W. Y., Brumme, Z. L., Brumme, C. J., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2706.210532 · Cited by 41

Scabies in AIDS.

Orkin, M. (1993) · PubMed · Cited by 41

Tracking the circulating SARS-CoV-2 variant of concern in South Africa using wastewater-based epidemiology

Johnson, R., Sharma, J. R., Ramharack, P., Mangwana, N., Kinnear, C. J., Viraragavan, A., Glanzmann, B., Louw, J., Abdelatif, N., Reddy, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05110-4 · Cited by 42

A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis

Aoki, A., Adachi, H., Mori, Y., Ito, M., Sato, K., Okuda, K., Sakakibara, T., Okamoto, Y., & Jinno, H. (2021) · The Journal of Toxicological Sciences · doi:10.2131/jts.46.471 · Cited by 38

The localized rise of a B.1.526 SARS-CoV-2 variant containing an E484K mutation in New York StatePreprint

Lasek‐Nesselquist, E., Lapierre, P., Schneider, E., George, K. S., & Pata, J. D. (2021) · medRxiv · doi:10.1101/2021.02.26.21251868 · Cited by 38

Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis

Negi, S. S., Schein, C. H., & Braun, W. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-04950-4 · Cited by 35

Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era

Harrison, C. M., Doster, J. M., Landwehr, E. H., Kumar, N. P., White, E. J., Beachboard, D. C., & Stobart, C. C. (2023) · Microorganisms · doi:10.3390/microorganisms11020445 · Cited by 41

Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule

da Silva, F. L. B., Giron, C. C., & Laaksonen, A. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c04225 · Cited by 31

SARS-CoV-2 variants: Impact on biological and clinical outcome

Mahilkar, S., Agrawal, S. R., Chaudhary, S., Parikh, S., Sonkar, S. C., Verma, D. K., Chitalia, V., Mehta, D., Koner, B. C., Vijay, N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995960 · Cited by 36

The time to offer treatments for COVID-19

Ngo, B., Marik, P. E., Kory, P. D., Shapiro, L., Thomadsen, R., Iglesias, J. I., Ditmore, S., Rendell, M., Varón, J., Dubé, M. P., et al. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1901883 · Cited by 31

The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines

Jiang, Y., Wu, Q. Y., Song, P., & You, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.806641 · Cited by 34

Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences

Olsen, R. J., Christensen, P. A., Long, S. W., Subedi, S., Hodjat, P., Olson, R., Nguyen, M., Davis, J. J., Yerramilli, P., Saavedra, M. O., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.002 · Cited by 30

A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2

Yuan, Y., Zhang, X., Chen, R., Li, Y., Wu, B., Li, R., Zou, F., Ma, X., Wang, X., Chen, Q., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110256 · Cited by 31

Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission

Sachs, J. D., Abdool Karim, S., Aknin, L., Allen, J., Brosbøl, K., Cuevas Barron, G., Daszak, P., Fernanda Espinosa, M., Gaspar, V., Gaviria, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00388-3 · Cited by 30

The Emergence and Spread of Novel SARS-CoV-2 Variants

Yi, H., Wang, J., Wang, J., Lu, Y., Zhang, Y., Peng, R., Lu, J., & Chen, Z. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.696664 · Cited by 29

Single‐dose immunisation with a multimerised SARS‐CoV‐2 receptor binding domain (RBD) induces an enhanced and protective response in mice

Salzer, R., Clark, J. J., Vaysburd, M., Chang, V. T.-C., Albecka, A., Kiss, L., Sharma, P., Llamazares, A. G., Kipar, A., Hiscox, J. A., et al. (2021) · FEBS Letters · doi:10.1002/1873-3468.14171 · Cited by 31

Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis

Lee, E.-J., & Oh, J. E. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0075 · Cited by 30

Effective and scalable clustering of SARS-CoV-2 sequences

Ali, S., Ali, T. E., Khan, M. A., Khan, I., & Patterson, M. (2021) · International Conference Big Data Research · doi:10.1145/3505745.3505752 · Cited by 29

Data-driven analysis of amino acid change dynamics timely reveals SARS-CoV-2 variant emergence

Bernasconi, A., Mari, L., Casagrandi, R., & Ceri, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00496-z · Cited by 26

Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations

Showers, W. M., Leach, S. M., Kechris, K. J., & Strong, M. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105153 · Cited by 35

Genomic Epidemiology of SARS-CoV-2 Divulge B.1, B.1.36, and B.1.1.7 as the Most Dominant Lineages in First, Second, and Third Wave of SARS-CoV-2 Infections in Pakistan

Basheer, A., & Zahoor, I. (2021) · Microorganisms · doi:10.3390/microorganisms9122609 · Cited by 28

SARS‐CoV‐2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time‐course study – potential challenge for vaccines and therapies

Weber, S., Ramirez, C. M., Weiser, B., Burger, H., & Doerfler, W. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114062 · Cited by 26

VirusViz: comparative analysis and effective visualization of viral nucleotide and amino acid variants

Bernasconi, A., Gulino, A., Alfonsi, T., Canakoglu, A., Pinoli, P., Sandionigi, A., & Ceri, S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab478 · Cited by 27

Decomposing the sources of SARS-CoV-2 fitness variation in the United States

Kepler, L. M., Hamins-Puértolas, M., & Rasmussen, D. A. (2021) · Virus Evolution · doi:10.1093/ve/veab073 · Cited by 24

Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 — Colorado, January–March 2021

Webb, L. M., Matzinger, S. R., Grano, C., Kawasaki, B., Stringer, G., Bankers, L., & Herlihy, R. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7019e2 · Cited by 26

Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates

Daou, M., Kannout, H., Khalili, M., Almarei, M., Alhashami, M., Alhalwachi, Z., Alshamsi, F. Y., Bataineh, M. T. A., Kayasseh, M. A., AlKhajeh, A. S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274961 · Cited by 26

Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants

Spratt, A. N., Kannan, S. R., Woods, L. T., Weisman, G. A., Quinn, T. P., Lorson, C. L., Sönnerborg, A. B., Byrareddy, S. N., & Singh, K. D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.037 · Cited by 25

Toward Mail-in-Sensors for SARS-CoV-2 Detection: Interfacing Gel Switch Resonators with Cell-Free Toehold Switches

Carr, A. R., Dopp, J. L., Wu, K., Mousavi, P. S., Jo, Y. R., McNeley, C. E., Lynch, Z. T., Pardee, K., Green, A. A., & Reuel, N. F. (2022) · ACS Sensors · doi:10.1021/acssensors.1c02450 · Cited by 26

Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction

Sathi, S. N., Umasankar, P. K., Sreekumar, E., Nair, R. R., Joseph, I., Nori, S. R. C., Philip, J. S., Prasad, R., Navyasree, K. V., Ramesh, S. T., et al. (2022) · BMC Molecular and Cell Biology · doi:10.1186/s12860-021-00403-4 · Cited by 26

SARS-CoV-2 variants: A double-edged sword?

Jogalekar, M. P., Veerabathini, A., & Gangadaran, P. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211014146 · Cited by 24

The challenge of emerging SARS-CoV-2 mutants to vaccine development

Li, R., Liu, J., & Zhang, H. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.03.001 · Cited by 25

Immune evasion of SARS-CoV-2 variants of concern is driven by low affinity to neutralizing antibodies

Ferraz, M. V. F., Moreira, E. G., Coêlho, D. F., Wallau, G. L., & Lins, R. D. (2021) · Chemical Communications · doi:10.1039/d1cc01747k · Cited by 24

Mutations of SARS-CoV-2 and their impact on disease diagnosis and severity

Alquraan, L. T., Alzoubi, K. H., & Rababa'h, S. Y. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101256 · Cited by 27

An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern

Morris, C. P., Luo, C. H., Amadi, A., Schwartz, M. C., Gallagher, N., Ray, S. C., Pekosz, A. S., & Mostafa, H. H. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab636 · Cited by 25

Virus Corona (SARS-CoV-2) penyebab COVID-19 kini telah bermutasi

Parwanto, E. (2021) · Jurnal Biomedika dan Kesehatan · doi:10.18051/jbiomedkes.2021.v4.47-49 · Cited by 24

Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies

Stefan, M. A., Light, Y. K., Schwedler, J. L., McIlroy, P. R., Courtney, C. M., Saada, E. A., Thatcher, C. E., Phillips, A. M., Bourguet, F. A., Mageeney, C. M., et al. (2021) · mAbs · doi:10.1080/19420862.2021.1958663 · Cited by 25

Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern

Clark, A. E., Wang, Z., Ostman, E., Zheng, H., Yao, H., Cantarel, B. L., Kanchwala, M., Xing, C., Chen, L., Irwin, P., et al. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac081 · Cited by 23

Efficient Approximate Kernel Based Spike Sequence Classification

Ali, S., Sahoo, B., Khan, M. A., Zelikovsky, A., Khan, I., & Patterson, M. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3206284 · Cited by 23

A hospital-related outbreak of SARS-CoV-2 associated with variant Epsilon (B.1.429) in Taiwan: transmission potential and outbreak containment under intensified contact tracing, January–February 2021

Akhmetzhanov, A. R., Jung, S.-M., Cheng, H., & Thompson, R. N. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.06.028 · Cited by 22

SARS-CoV-2 Variants and Vaccination

Liu, Y., Liu, J., & Shi, P. (2022) · Zoonoses · doi:10.15212/zoonoses-2022-0001 · Cited by 22

Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants

Neamțu, A., Mocci, F., Laaksonen, A., & da Silva, F. L. B. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112986 · Cited by 23

Los Angeles County SARS-CoV-2 Epidemic: Critical Role of Multi-generational Intra-household Transmission

Harris, J. E. (2021) · Journal of Bioeconomics · doi:10.1007/s10818-021-09310-2 · Cited by 22

High‐resolution melting curve FRET‐PCR rapidly identifies SARS‐CoV‐2 mutations

Barua, S., Hoque, M. M., Kelly, P. J., Bai, J., Hanzlicek, G., Noll, L. W., Walz, H., Johnson, C. M., Kyriakis, C. S., & Wang, C. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27139 · Cited by 21

From Alpha to Zeta: Identifying Variants and Subtypes of SARS-CoV-2 Via Clustering

Melnyk, A., Mohebbi, F., Knyazev, S., Sahoo, B., Hosseini, R., Skums, P., Zelikovsky, A., & Patterson, M. (2021) · Journal of Computational Biology · doi:10.1089/cmb.2021.0302 · Cited by 21

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy

Damavandi, A. R., Dowran, R., Sharif, S. A., Kashanchi, F., & Jafari, R. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00729-6 · Cited by 21

A tale of three SARS-CoV-2 variants with independently acquired P681H mutations in New York StatePreprint

Lasek‐Nesselquist, E., Pata, J. D., Schneider, E., & George, K. S. (2021) · medRxiv · doi:10.1101/2021.03.10.21253285 · Cited by 22

Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapePreprint

Starr, T. N., Czudnochowski, N., Zatta, F., Park, Y., Liu, Z., Addetia, A., Pinto, D., Beltramello, M., Hernandez, P., Greaney, A. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.06.438709 · Cited by 24

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

Jeda, A. S., Abbassi, S., Mousavizadeh, A., Esghaie, M., Bokharaei‐Salim, F., Jeddi, F., Shafaati, M., & Abdoli, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108232 · Cited by 22

A phylogeny-based metric for estimating changes in transmissibility from recurrent mutations in SARS-CoV-2Preprint

Richard, D., Shaw, L. P., Lanfear, R., Corbett-Detig, R. B., Hinrichs, A. S., McBroome, J., Turakhia, Y., Acman, M., Owen, C. J., Tan, C. C. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.06.442903 · Cited by 20

Variantes de SARS-CoV-2, una historia todavía inacabada

Pérez-Abeledo, M., & Moreno, J. C. S. (2021) · Vacunas · doi:10.1016/j.vacun.2021.06.003 · Cited by 20

COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies

Malcangi, G., Inchingolo, A. D., Inchingolo, A. M., Santacroce, L., Marinelli, G., Mancini, A., Vimercati, L., Maggiore, M. E., D’Oria, M. T., Hazballa, D., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9091964 · Cited by 31

Intra-Host Evolution Provides for Continuous Emergence of SARS-CoV-2 Variants

Landis, J. T., Moorad, R., Pluta, L., Caro‐Vegas, C., McNamara, R. P., Eason, A. B., Bailey, A., Villamor, F. C. S., Juarez, A., Wong, J. P., et al. (2021) · mBio · doi:10.1128/mbio.03448-22 · Cited by 20

Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)

Wu, T., Kang, S., Peng, W., Zuo, C., Zhu, Y., Pan, L., Fu, K., You, Y., Yang, X., Luo, X., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.702066 · Cited by 21

Possible Roles of Permafrost Melting, Atmospheric Transport, and Solar Irradiance in the Development of Major Coronavirus and Influenza Pandemics

Hofmeister, A. M., Seckler, J. M., & Criss, G. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063055 · Cited by 18

Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor

Nguyen, K. V. (2021) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2021.1914851 · Cited by 18

Previously infected vaccinees broadly neutralize SARS-CoV-2 variantsPreprint

Leier, H. C., Bates, T. A., Lyski, Z. L., McBride, S. K., Lee, D. X., Coulter, F. J., Goodman, J. R., Lu, Z., Curlin, M. E., Messer, W. B., et al. (2021) · medRxiv · doi:10.1101/2021.04.25.21256049 · Cited by 17

Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America

Quinonez, E., Vahed, M., Shahraki, A. H., & Mirsaeidi, M. S. (2021) · Viruses · doi:10.3390/v13050930 · Cited by 16

Evaluation of a Rapid and Accessible Reverse Transcription-Quantitative PCR Approach for SARS-CoV-2 Variant of Concern Identification

Yeung, P. S.-W., Wang, H., Sibai, M., Solis, D., Yamamoto, F. F., Iwai, N., Jiang, B., Hammond, N. A., Truong, B., Bihon, S., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00178-22 · Cited by 18

COVID-19 reinfection

Shaheen, N. A., Sambas, R., Alenezi, M., Alharbi, N. K., Aldibasi, O. S., & Bosaeed, M. (2022) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_74_22 · Cited by 17

Vaccine against COVID-19

Picazo, J. J. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/085.2021 · Cited by 22

Monitoring the propagation of SARS CoV2 variants by tracking identified mutation in wastewater using specific RT-qPCRPreprint

Wurtzer, S., Waldman, P., Levert, M., Mouchel, J., Gorgé, O., Boni, M., Maday, Y., Maréchal, V., & Moulin, L. (2021) · medRxiv · doi:10.1101/2021.03.10.21253291 · Cited by 16

Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination

Delshad, M., Sanaei, M., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109128 · Cited by 18

Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential

Kubik, S., Arrigo, N., Bonet, J., & Xu, Z. (2021) · Viruses · doi:10.3390/v13112114 · Cited by 16

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently emerging RBD mutationsPreprint

Bertoglio, F., Fühner, V., Ruschig, M., Heine, P. A., Abasi, L., Klünemann, T., Rand, U., Meier, D., Langreder, N., Steinke, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.03.409318 · Cited by 18

Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike proteinPreprint

Mallm, J., Bundschuh, C., Kim, H., Weidner, N., Steiger, S., Lander, I., Börner, K., Bauer, K., Hübschmann, D., Beneš, V., et al. (2021) · medRxiv · doi:10.1101/2021.04.27.21254849 · Cited by 16

Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination

Stampfer, S. D., Goldwater, M., Bujarski, S. E., Regidor, B. S. S., Zhang, W., Feinstein, A. J., Swift, R. A., Eshaghian, S., Vail, E., & Berenson, J. R. (2021) · Clinical Infection in Practice · doi:10.1016/j.clinpr.2021.100130 · Cited by 15

Nonclinical safety assessment of an mRNA Covid‐19 vaccine candidate following repeated administrations and biodistribution

Broudic, K., Laurent, S., Perkov, V., Simon, C., Garinot, M., Truchot, N., Latour, J., & Désert, P. (2023) · Journal of Applied Toxicology · doi:10.1002/jat.4548 · Cited by 15

Challenges in Emerging Vaccines and Future Promising Candidates against SARS‐CoV‐2 Variants

Ghildiyal, T., Rai, N., Rawat, J. M., Singh, M., Anand, J., Pant, G., Kumar, G., & Shidiki, A. (2024) · Journal of Immunology Research · doi:10.1155/2024/9125398 · Cited by 16

In silico approach to design a multi-epitopic vaccine candidate targeting the non-mutational immunogenic regions in envelope protein and surface glycoprotein of SARS-CoV-2

Mugunthan, S. P., Kirubakaran, S. I., & Harish, M. C. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1977702 · Cited by 15

The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review

Figueroa-Pizano, M. D., Campa-Mada, A. C., Carvajal‐Millán, E., Martinez-Robinson, K. G., & Chu, A. R. (2021) · AIMS Public Health · doi:10.3934/publichealth.2021057 · Cited by 15

Is Omicron the last SARS-CoV-2 Variant of Concern?

Rahimi, F., & Abadi, A. T. B. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.01.001 · Cited by 15

Predicting COVID-19 outcomes from clinical and laboratory parameters in an intensive care facility during the second wave of the pandemic in South Africa

Allwood, B., Koegelenberg, C. F. N., Ngah, V., Sigwadhi, L. N., Irusen, E. M., Lalla, U., Yalew, A., Tamuzi, J. L., McAllister, M., Zemlin, A. E., et al. (2022) · IJID Regions · doi:10.1016/j.ijregi.2022.03.024 · Cited by 15

Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies

Giron, C. C., Laaksonen, A., & da Silva, F. L. B. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2095305 · Cited by 18

Novel coronavirus mutations: Vaccine development and challenges

Luo, W.-R., Wu, X., Wang, W., Yu, J., Chen, Q., Zhou, X., Huang, X., Pan, H., Liu, Z., Gao, Y., et al. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105828 · Cited by 15

Peptides and peptidomimetics as therapeutic agents for Covid‐19

Dahal, A., Sonju, J. J., Kousoulas, K. G., & Jois, S. D. S. (2021) · Peptide Science · doi:10.1002/pep2.24245 · Cited by 14

Variantes del SARS-CoV-2: epidemiología, fisiopatología y la importancia de las vacunas

Bedoya-Sommerkamp, M., Medina-Ranilla, J., Rodriguez, V. H. C., Li-Soldevilla, R., Vera-Albújar, Á., & Garcia, P. J. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.383.8734 · Cited by 13

Effect of Double Mutation (L452R and E484Q) on the Binding Affinity of Monoclonal Antibodies (mAbs) against the RBD—A Target for Vaccine Development

Gupta, D., Kumar, M., Sharma, P., Mohan, T., Prakash, A., Kumari, R., & Kaur, P. (2022) · Vaccines · doi:10.3390/vaccines11010023 · Cited by 14

SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression

Hussein, H. A. M., Thabet, A. A., Wardany, A. A., El-Adly, A. M., Ali, M. E., Hassan, M. E. A., Abdeldayem, M. A. B., Mohamed, A.-R. M. A., Sobhy, A., El‐Mokhtar, M. A., et al. (2024) · Virology Journal · doi:10.1186/s12985-024-02342-w · Cited by 17

Evolutionary dynamics of the severe acute respiratory syndrome coronavirus 2 genomes

Qian, Z., Li, P., Tang, X., & Lü, J. (2022) · Medical Review · doi:10.1515/mr-2021-0035 · Cited by 14

Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike

Tan, T. S., Toyoda, M., Ode, H., Barabona, G., Hamana, H., Kitamatsu, M., Kishi, H., Motozono, C., Iwatani, Y., & Ueno, T. (2022) · Journal of Virology · doi:10.1128/jvi.01162-22 · Cited by 14

How Do Point Mutations Enhancing the Basic Character of the RBDs of SARS-CoV-2 Variants Affect Their Transmissibility and Infectivity Capacities?

Barre, A., Klonjkowski, B., Benoist, H., & Rougé, P. (2022) · Viruses · doi:10.3390/v14040783 · Cited by 14

Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation

Kostaki, E. G., Tseti, I. K., Tsiodras, S., Pavlakis, G. N., Sfikakis, P. P., & Paraskevis, D. N. (2021) · Life · doi:10.3390/life11050375 · Cited by 13

The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R

Mor, O., Mandelboim, M., Fleishon, S., Bucris, E. D., Bar-Ilan, D., Linial, M., Nemet, I., Kliker, L., Lustig, Y., Mendelson, E., et al. (2021) · Vaccines · doi:10.3390/vaccines9080937 · Cited by 14

Structural basis of fitness of emerging SARS-COV-2 variants and considerations for screening, testing and surveillance strategy to contain their threatPreprint

Islam, S. R., Prusty, D., & Manna, S. K. (2021) · medRxiv · doi:10.1101/2021.01.28.21250666 · Cited by 13

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Alter, G., Yu, J., Liu, J., Chandrashekar, A., Borducchi, E. N., Tostanoski, L. H., McMahan, K., Jacob-Dolan, C., Martinez, D., Chang, A., et al. (2021) · immuneACCESS · doi:10.21417/ga2021n · Cited by 19

SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients

Wang, A. X., Busque, S., Kuo, J., Singh, U., Röltgen, K., Pinsky, B. A., Chertow, G. M., Scandling, J. D., & Lenihan, C. R. (2021) · Kidney360 · doi:10.34067/kid.0005732021 · Cited by 13

Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines

Pecetta, S., Kratochvil, S., Kato, Y., Vadivelu, K., & Rappuoli, R. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000285 · Cited by 11

Immune response variables and viral mutations impact on COVID-19 reinfection and relapse

Sanaie, S., Golipour, E., Shamekh, A., Sadaie, M. R., Mahmoodpoor, A., & Yousefi, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108108 · Cited by 12

COVID-19 vaccine candidates and vaccine development platforms available worldwide

Duman, N., Alzaidi, Z., Aynekin, B., Taskin, D., Demirors, B., Yildirim, A., Şahin, İ. O., Bilgili, F., Turanlı, E. T., Beccari, T., et al. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.09.004 · Cited by 12

SARS-CoV-2 variants, a still unfinished story

Pérez-Abeledo, M., & Moreno, J. C. S. (2021) · Vacunas (English Edition) · doi:10.1016/j.vacune.2021.10.003 · Cited by 12

Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q

Ahamad, S., Hema, K., Ahmad, S., Kumar, V., & Gupta, D. K. (2022) · 3 Biotech · doi:10.1007/s13205-022-03151-0 · Cited by 14

Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2

Foix, A., López, D., Díez‐Fuertes, F., McConnell, M. J., & Martín-Galiano, A. J. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009726 · Cited by 12

Substantial impact of post-vaccination contacts on cumulative infections during viral epidemics

Rochman, N. D., Wolf, Y. I., & Koonin, E. V. (2021) · F1000Research · doi:10.12688/f1000research.52341.1 · Cited by 10

Estimating the relative proportions of SARS-CoV-2 haplotypes from wastewater samples

Pipes, L., Chen, Z., Afanaseva, S., & Nielsen, R. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100313 · Cited by 12

SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise

Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12

Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants

Tchesnokova, V. L., Kulasekara, H. D., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-21 · Cited by 214

Genomic epidemiology of the Los Angeles COVID-19 outbreak and the early history of the B.1.43 strain in the USA

Guo, L., Boocock, J., Hilt, E. E., Chandrasekaran, S., Zhang, Y., Munugala, C., Sathe, L., Alexander, N., Arboleda, V. A., Jonathan Flint, C., et al. (2022) · BMC Genomics · doi:10.1186/s12864-022-08488-7 · Cited by 2

Genomic Epidemiology of the Los Angeles COVID-19 OutbreakPreprint

Guo, L., Boocock, J., Hilt, E. E., Chandrasekaran, S., Zhang, Y., Munugala, C., Sathe, L., Alexander, N., Arboleda, V. A., Jonathan Flint, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-423686/v1 · Cited by 1

Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants

Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2021) · Communications Biology · doi:10.1038/s42003-021-01754-6 · Cited by 201

Emergence and Evolution of a Prevalent New SARS-CoV-2 Variant in the United StatesPreprint

Pater, A. A., Bosmeny, M. S., Barkau, C. L., Ovington, K. N., Chilamkurthy, R., Parasrampuria, M., Eddington, S. B., Yinusa, A. O., White, A. A., Metz, P. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.426287 · Cited by 37